中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Immune Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
Upcoming Events
Corporate presentation
SCIENTIFIC PRESENTATIONS
News
Careers
Replay of 2025 Interim Results Conference Call (Mandarin) at August 18
Ascletis Pharma(1672.HK)2025 Interim Results Conference Call.mp3
浙公网安备 33010802003344号
浙ICP备11050387号-1
